Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| 9115 | 9115 | Portugal | 2010 | HIV1 | B | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | EFV+FTC+TDF | 43 |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| K65KR, K70KE, M184V | D67DG, T215C | L100I, K103N | A98G | V60I, D123E, I135T, E169D, K173R, Q174K, D177E, T200A |
| >9115| codons 40-237 EMEKEGKISKIGPENPYNTPIFAIKRKGSTEWRKLVDFRELNKRTQDFWEVQLGIPHPGG IKKNKSVTVLDVGDAYFSVPLDKEFRKYTAFTIPSTNNETPGIRYQYNVLPQGWKGSPAI FQSSMTKILDPFRRKNPEIVIYQYVDDLYVGSDLEIGQHRAKIEELRQHLLRWGFCTPDK KHQKEPPFLWMGYELHPD |
References
| Author | Title | Citation |
| Theys, K | HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir. | AAC, 2013 |
| Rhee, SY | Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration. | EBioMedicine, 2017 |